etidronate has been researched along with Chronic Disease in 17 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Alendronate was the most frequently implicated (six cases) and risedronate (five cases)." | 1.36 | [Jaw osteonecrosis induced by oral biphosphonates: 12 cases]. ( Barrier, A; Descroix, V; Goudot, P; Lescaille, G; Rigolet, A; Ruhin, B, 2010) |
| "We studied the bone resorption state in GC-treated CKD patients and the effects of bisphosphonate on S-NTX." | 1.33 | Serum NTX is a practical marker for assessing antiresorptive therapy for glucocorticoid treated patients with chronic kidney disease. ( Fujii, N; Hamano, T; Horio, M; Imai, E; Isaka, Y; Ito, T; Moriyama, T; Nagasawa, Y; Okada, N, 2006) |
| "A case is reported of progressive ossifying myositis (fibrodysplasia ossificans progressiva, Münchmeyer's disease) with onset at 16 years of age by a lesion of internal pterygoid with limitation of opening of mouth." | 1.27 | [Permanent constriction of the jaws due to progressive ossifying myositis]. ( Bouvier, R; Delmas, P; Freidel, M; Seguin, P, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (17.65) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pomozi, V | 1 |
| Brampton, C | 1 |
| van de Wetering, K | 1 |
| Zoll, J | 1 |
| Calio, B | 1 |
| Pham, K | 1 |
| Owens, JB | 1 |
| Marh, J | 1 |
| Moisyadi, S | 1 |
| Váradi, A | 1 |
| Martin, L | 1 |
| Bauer, C | 1 |
| Erdmann, J | 1 |
| Aherrahrou, Z | 1 |
| Le Saux, O | 1 |
| Seleznev, AN | 1 |
| Sabilo, ES | 1 |
| Savin, AA | 1 |
| Riabov, AG | 1 |
| Kozlov, SA | 1 |
| Zima, LN | 1 |
| Zmievskoĭ, GN | 1 |
| Kunchur, R | 1 |
| Need, A | 1 |
| Hughes, T | 1 |
| Goss, A | 1 |
| Sato, Y | 1 |
| Iwamoto, J | 1 |
| Honda, Y | 1 |
| Barrier, A | 1 |
| Lescaille, G | 1 |
| Rigolet, A | 1 |
| Descroix, V | 1 |
| Goudot, P | 1 |
| Ruhin, B | 1 |
| Yurci, A | 1 |
| Kalkan, AO | 1 |
| Ozbakir, O | 1 |
| Karaman, A | 1 |
| Torun, E | 1 |
| Kula, M | 1 |
| Baskol, M | 1 |
| Gursoy, S | 1 |
| Yucesoy, M | 1 |
| Bayram, F | 1 |
| Konrat, C | 1 |
| Boutron, I | 1 |
| Trinquart, L | 1 |
| Auleley, GR | 1 |
| Ricordeau, P | 1 |
| Ravaud, P | 1 |
| Mori, H | 1 |
| Okada, Y | 1 |
| Tanaka, Y | 1 |
| Hashimoto, O | 1 |
| Wright, SA | 1 |
| Millar, AM | 1 |
| Coward, SM | 1 |
| Finch, MB | 1 |
| Hamano, T | 2 |
| Fujii, N | 2 |
| Nagasawa, Y | 2 |
| Isaka, Y | 2 |
| Moriyama, T | 2 |
| Okada, N | 1 |
| Imai, E | 2 |
| Horio, M | 2 |
| Ito, T | 2 |
| Mikami, S | 1 |
| Hori, M | 1 |
| Arase, Y | 1 |
| Suzuki, F | 1 |
| Suzuki, Y | 1 |
| Akuta, N | 1 |
| Kobayashi, M | 1 |
| Kawamura, Y | 1 |
| Yatsuji, H | 1 |
| Sezaki, H | 1 |
| Hosaka, T | 1 |
| Ikeda, K | 1 |
| Kumada, H | 1 |
| Pazzaglia, UE | 1 |
| Beluffi, G | 1 |
| Ravelli, A | 1 |
| Zatti, G | 1 |
| Martini, A | 1 |
| Skingle, SJ | 1 |
| Moore, DJ | 1 |
| Crisp, AJ | 1 |
| Grames, GM | 1 |
| Jansen, C | 1 |
| Carlsen, EN | 1 |
| Davidson, TR | 1 |
| Seguin, P | 1 |
| Delmas, P | 1 |
| Bouvier, R | 1 |
| Freidel, M | 1 |
| Schneider, HG | 1 |
| Minne, HW | 1 |
| Raue, F | 1 |
| Fichtner, HJ | 1 |
| Baldauf, G | 1 |
| Ziegler, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Intestinal Microbiota and Vitamin K Levels in PXE Patients (IMPROVE Study)[NCT03813550] | 20 participants (Anticipated) | Interventional | 2019-01-21 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for etidronate and Chronic Disease
| Article | Year |
|---|---|
[Kidney and bone update : the 5-year history and future of CKD-MBD. Bisphosphonates treatment for chronic kidney disease-mineral and bone disorder].
Topics: Bone Density Conservation Agents; Bone Diseases, Metabolic; Chronic Disease; Diphosphonates; Etidron | 2012 |
6 trials available for etidronate and Chronic Disease
| Article | Year |
|---|---|
[Mechanisms of formation of chronic low back pain relapse and their correction in patients with dorsopathy].
Topics: Algorithms; Anxiety; Bone Density Conservation Agents; Chronic Disease; Depression; Disease Progress | 2008 |
Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws.
Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Alendronate; Biomarkers; Bone Density Co | 2009 |
RETRACTED: Beneficial effect of etidronate therapy in chronically hospitalized, disabled patients with stroke.
Topics: Aged; Body Mass Index; Bone Density; Bone Density Conservation Agents; Calcium; Chronic Disease; Dis | 2010 |
Efficacy of different therapeutic regimens on hepatic osteodystrophy in chronic viral liver disease.
Topics: Absorptiometry, Photon; Adult; Alendronate; Biomarkers; Bone Density; Bone Density Conservation Agen | 2011 |
Risedronate, an effective treatment for glucocorticoid-induced bone loss in CKD patients with or without concomitant active vitamin D (PRIUS-CKD).
Topics: Adult; Bone Density Conservation Agents; Bone Resorption; Chronic Disease; Drug Therapy, Combination | 2007 |
Cyclical etidronate increases lumbar spine bone density in patients on long-term glucocorticosteroid therapy.
Topics: Adult; Aged; Aged, 80 and over; Bone Demineralization, Pathologic; Bone Density; Chronic Disease; Et | 1997 |
10 other studies available for etidronate and Chronic Disease
| Article | Year |
|---|---|
Pyrophosphate Supplementation Prevents Chronic and Acute Calcification in ABCC6-Deficient Mice.
Topics: Acute Disease; Animals; ATP-Binding Cassette Transporters; Calcinosis; Chronic Disease; Diphosphates | 2017 |
[Jaw osteonecrosis induced by oral biphosphonates: 12 cases].
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Alendronate; Autoimmu | 2010 |
Underrepresentation of elderly people in randomised controlled trials. The example of trials of 4 widely prescribed drugs.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Chronic Disease; Etidronic Acid; Fluorobenzenes; France | 2012 |
Chronic diffuse sclerosing osteomyelitis treated with risedronate.
Topics: Adult; Calcium Channel Blockers; Chronic Disease; Etidronic Acid; Female; Humans; Osteomyelitis; Pai | 2005 |
Serum NTX is a practical marker for assessing antiresorptive therapy for glucocorticoid treated patients with chronic kidney disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Body Mass Index; Bone Density; Bone Density | 2006 |
Prolonged-efficacy of bisphosphonate in postmenopausal women with osteoporosis and chronic liver disease.
Topics: Aged; Bone Density Conservation Agents; Chronic Disease; Etidronic Acid; Female; Fractures, Bone; He | 2008 |
Chronic intoxication by ethane-1-hydroxy-1,1-diphosphonate (EHDP) in a child with myositis ossificans progressiva.
Topics: Adolescent; Chronic Disease; Etidronic Acid; Humans; Male; Myositis Ossificans; Radiography | 1993 |
The abnormal bone scan in intracranial lesions.
Topics: Adult; Aged; Astrocytoma; Brain; Brain Diseases; Brain Neoplasms; Cerebral Angiography; Choroid Plex | 1975 |
[Permanent constriction of the jaws due to progressive ossifying myositis].
Topics: Adolescent; Ankylosis; Chronic Disease; Combined Modality Therapy; Diphosphonates; Etidronic Acid; F | 1987 |
[Extraosseous calcification in juvenile dermatomyositis. The ineffectiveness of EHDP].
Topics: Adult; Calcinosis; Chronic Disease; Dermatomyositis; Drug Evaluation; Drug Therapy, Combination; Eti | 1988 |